Home / Drugs / Dysport (abobotulinumtoxinA)

Dysport (abobotulinumtoxinA)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

July 2016

ADVERSE REACTIONS

The following serious adverse reactions are discussed below and elsewhere in labeling: (additions)

About Tess Bryan

Tess Bryan is an influential Health & Travel blogger helping businesses worldwide to connect with their ideal audience and sharing great citizen journalism. Connect with her via Linkedin to share your story.

Check Also

The opioid crisis in the US is reaching peak levels

Underneath the war on drugs we may face a broken system

As the phenomenon of medical tourism is growing internationally and US politicians seek to find …